TickerKhojComparison · NSE · data 2026-11-03
Abbott India Limited vs Glenmark Pharmaceuticals Limited
In plain words
Size: Glenmark Pharmaceuticals Limited is about 1.2 times the market value of Abbott India Limited.
Return on equity: Abbott India Limited 34.5% vs Glenmark Pharmaceuticals Limited 14.1%.
Profit growth over 3 years: Glenmark Pharmaceuticals Limited 66.1% a year vs Abbott India Limited 17.8% a year.
Debt to equity: Glenmark Pharmaceuticals Limited 0.06 vs Abbott India Limited 0.04.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ABBOTINDIA | GLENMARK | |
|---|---|---|
| Price | ₹25,820 | ₹2,382 |
| Market cap | ₹54,384 cr | ₹65,137 cr |
| P/E | 34 | 37.4 |
| P/B | — | — |
| ROE | 34.5% | 14.1% |
| ROCE | 39.1% | 29.2% |
| Debt / equity | 0.04 | 0.06 |
| Operating margin | 27.5% | 20.2% |
| Dividend yield | 2.05% | 0.22% |
| Sales growth, 3 years (yearly) | 9.0% | 13.6% |
| Profit growth, 3 years (yearly) | 17.8% | 66.1% |
| 1-year return | -12.8% | 26.5% |
| Revenue, last 12 months | ₹7,004 cr | ₹17,737 cr |
| Net profit, last 12 months | ₹1,615 cr | ₹1,798 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹483 cr |
| Quarter profit vs a year earlier | — | +930.3% |
| Promoter holding | — | 46.65% |
| Health check | Strong (7.2/10) | Strong (8.3/10) |
Common questions
Which has a higher P/E, Abbott India Limited or Glenmark Pharmaceuticals Limited?
Glenmark Pharmaceuticals Limited trades at the higher P/E (37.4 against 34). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Abbott India Limited (34.5% against 14.1%).
Which carries more debt?
Glenmark Pharmaceuticals Limited has the higher debt-to-equity ratio (0.06 against 0.04).